Shopping Cart
- Remove All
- Your shopping cart is currently empty
NCL1, a phenylcyclopropylamine (PCPA)-based Lysine-specific demethylase 1 (LSD1) inhibitor, selectively inhibits LSD1 over LSD2, with IC50 values of 2.5 μM for LSD1 and 26 μM for LSD2 [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | NCL1, a phenylcyclopropylamine (PCPA)-based Lysine-specific demethylase 1 (LSD1) inhibitor, selectively inhibits LSD1 over LSD2, with IC50 values of 2.5 μM for LSD1 and 26 μM for LSD2 [1]. |
Targets&IC50 | LSD1:2.5 ± 0.5 μM |
Molecular Weight | 443.54 |
Formula | C27H29N3O3 |
Cas No. | 1196119-03-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.